These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2982643)
61. Bradykinin analogs as inhibitors of angiotensin-converting enzyme. Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848 [TBL] [Abstract][Full Text] [Related]
62. Specific binding and proteolytic inactivation of bradykinin by membrane vesicles from pig intestinal smooth muscle. Schäfer G; Nau R; Cole T; Conlon M Biochem Pharmacol; 1986 Nov; 35(21):3719-25. PubMed ID: 3022739 [TBL] [Abstract][Full Text] [Related]
63. Physiological and enzymatic properties of the ram epididymal soluble form of germinal angiotensin I-converting enzyme. Métayer S; Dacheux F; Guérin Y; Dacheux JL; Gatti JL Biol Reprod; 2001 Nov; 65(5):1332-9. PubMed ID: 11673247 [TBL] [Abstract][Full Text] [Related]
64. In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat. Freer RJ; Stewart JM Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):97-109. PubMed ID: 172037 [TBL] [Abstract][Full Text] [Related]
65. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties. Deddish PA; Wang LX; Jackman HL; Michel B; Wang J; Skidgel RA; Erdös EG J Pharmacol Exp Ther; 1996 Dec; 279(3):1582-9. PubMed ID: 8968386 [TBL] [Abstract][Full Text] [Related]
66. Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9. Diekmann O; Tschesche H Braz J Med Biol Res; 1994 Aug; 27(8):1865-76. PubMed ID: 7538373 [TBL] [Abstract][Full Text] [Related]
67. Role of the chymotrypsin-like membrane-associated proteinase from Treponema denticola ATCC 35405 in inactivation of bioactive peptides. Mäkinen PL; Mäkinen KK; Syed SA Infect Immun; 1995 Sep; 63(9):3567-75. PubMed ID: 7543886 [TBL] [Abstract][Full Text] [Related]
68. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
69. ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin. Wösten-van Asperen RM; Lutter R; Haitsma JJ; Merkus MP; van Woensel JB; van der Loos CM; Florquin S; Lachmann B; Bos AP Eur Respir J; 2008 Feb; 31(2):363-71. PubMed ID: 17959639 [TBL] [Abstract][Full Text] [Related]
70. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. Drapeau G; deBlois D; Marceau F J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280 [TBL] [Abstract][Full Text] [Related]
71. Identification of the site of cleavage in angiotensin converting enzyme by its secretase. Hooper NM; Oppong SY; Turner AJ Biochem Soc Trans; 1995 Nov; 23(4):552S. PubMed ID: 8654737 [No Abstract] [Full Text] [Related]
72. A sensitive radiochemical assay for angiotensin-converting enzyme (kinase II). Chiu AT; Ryan JW; Ryan US Biochem J; 1975 Jul; 149(1):297-300. PubMed ID: 172070 [TBL] [Abstract][Full Text] [Related]
73. New substrates for the radioassay of angiotensin converting enzyme of endothelial cells in culture. Ryan JW; Chung A; Martin LC; Ryan US Tissue Cell; 1978; 10(3):555-62. PubMed ID: 31710 [TBL] [Abstract][Full Text] [Related]
74. Influence of the carboxyl terminus of luteinizing hormone-releasing hormone and bradykinin on hydrolysis by brain endo-oligopeptidases. De Camargo AC; Da Fonseca MJ; Caldo H; De Morais Carvalho K J Biol Chem; 1982 Aug; 257(16):9265-7. PubMed ID: 6286612 [TBL] [Abstract][Full Text] [Related]
75. Kininase II-type enzymes. Their putative role in muscle energy metabolism. Dragović T; Minshall R; Jackman HL; Wang LX; Erdös EG Diabetes; 1996 Jan; 45 Suppl 1():S34-7. PubMed ID: 8529798 [TBL] [Abstract][Full Text] [Related]
76. Interactions of kinins with angiotensin I converting enzyme (kininase II). Odya CE; Wilgis FP; Vavrek RJ; Stewart JM Biochem Pharmacol; 1983 Dec; 32(24):3839-47. PubMed ID: 6140924 [TBL] [Abstract][Full Text] [Related]
77. Kinetics of pulmonary angiotensin-converting enzyme and 5'-nucleotidase in vivo. Catravas JD; White RE J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1173-81. PubMed ID: 6094404 [TBL] [Abstract][Full Text] [Related]
78. Dipeptidyl carboxypeptidase from human seminal plasma. Depierre D; Bargetzi JP; Roth M Biochim Biophys Acta; 1978 Apr; 523(2):469-76. PubMed ID: 207335 [TBL] [Abstract][Full Text] [Related]
79. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
80. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Hooper NM; Kenny AJ; Turner AJ Biochem J; 1985 Oct; 231(2):357-61. PubMed ID: 2998348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]